1-Boc-5-(4,4,5,5-Tetramethyl-[1,3,2]dioxaborolan-2-yl)-benzoimidazole 更新时间：2022-08-12 21:07:44 采购接见：1次 常用名 TERT-BUTYL 5-(4,4,5,5-TETRAMETHYL-1,3,2-DIOXABOROLAN-2-YL)-1H-BENZO[D]IMIDAZOLE-1-CARBOXYLATE CAS号 1021918-86-4 价钱 $需询单/5g 纯度 98.2% 备货期 需询单 库存 现货 产物详情（用途，包装等） 物理化学性子： CAS号：1021918-86-4 常用中文名：TERT-BUTYL 5-(4,4,5,5-TETRAMETHYL-1,3,2-DIOXABOROLAN-2-YL)-1H-BENZO[D]IMIDAZOLE-1-CARBOXYLATE 常用英文名：TERT-BUTYL 5-(4,4,5,5-TETRAMETHYL-1,3,2-DIOXABOROLAN-2-YL)-1H-BENZO[D]IMIDAZOLE-1-CARBOXYLATE 分子式：C18H25BN2O4 分子量：344.21300 密度：N/A 沸点：N/A 熔点：N/A 闪点：N/A 供应商信息 EOS MED CHEM CO., LTD 认证状态： 已认证供应商 商品数： 9993件 电话： 0086-53169905422 地址： Jinan City, Shandong Province, China 区域： 山东省 济南市 市中区 联系人： EOS MED CHEM 联系人电话： 0086-531-69905422 邮件： order@eosmedchem.com 网址： www.eosmedchem.com 主要市场： Japan, South Korea, Europe and the United States 年商业额： About 70 million RMB EOS mainly serving new drug research and development institutions including CRO institutions and scientific research institutes. The identification of candidates and other key aspects of new drug development.Our building blocks are mainly used in drug target discovery, screening and optimization of hit compounds, screening and optimization of lead compounds, determination of clinical candidates and other key aspects of new drug R&D, which can greatly save R&D time and improve R&D efficiency. EOS Medchem is big in: New API and Intermediates, Custom synthesis MG: Pharma Impurity G: New small molecule and inhibitor KG: New drug Intermediates 100KG: New chemical CMO R&D Center: 4000 sq, More than 100 hoods Pilot Plant: 20000sq, 40 reactors from 5-200L Manufacturing Site: 800000sq, 40 reactors from 100-5000L Web: www.eosmedchem.com Email: info@eosmedchem.com ; eosmedchem@gmail.com; R&D youtube: youtu.be/r5cJdXKNXHk